Pyxis Oncology, Inc. Common Stock (NASDAQ: PYXS) last traded at $2.01, down 0.99% on the session. The quote above updates while this page is open; the figures below are drawn from Pyxis Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pyxis Oncology, Inc. Common Stock trades on NASDAQ under the ticker PYXS. Its market capitalisation is $167.65 million.
Valuation measures for Pyxis Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $167.65M |
|---|---|
| Enterprise value | $192.28M |
| Price / sales | 12.10 |
| Price / book | 14.65 |
| Beta | 1.29 |
Trailing-twelve-month figures tagged in Pyxis Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $13.86M |
|---|---|
| Net income (TTM) | -$88.73M |
| EPS (TTM) | -$1.40 |
| Gross margin | 82.77% |
| Operating margin | -664.64% |
| Return on equity | -775.59% |
| Cash | $18.86M |
Range and volume for PYXS over the past 52 weeks.
| 52-week high | $5.55 |
|---|---|
| 52-week low | $1.03 |
| Volume | 367.4K |
| Average volume | 1.24M |
| Previous close | $2.03 |
Invest a chosen dollar amount in Pyxis Oncology, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PYXS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.